Novo Holdings: Investment Portfolio & Startup News
Novo Holdings
To add a bio or update investment portfolio click update information.
Investment Portfolio
OMass Therapeutics
15 Oct 2026
OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
OMass Therapeutics is a biotechnology company developing small molecule therapeutics against highly validated target ecosystems in endocrinology and immunology. OMass Therapeutics develops OMS1620 for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome and advances an SLC15A4 inhibitor for lupus and related diseases.
Phasecraft
2 Sept 2025
Phasecraft raises £25m Series B led by Plural, Playground Global and Novo Holdings to help quantum computing solve real-world challenges
Phasecraft develops hardware-agnostic quantum algorithms that allow today’s quantum computers to solve practical problems, supporting applications in materials science, energy optimisation and industrial research without waiting for perfect hardware.
Novo Holdings
- 1(12 months)
- novoholdings.dk
More venture news
- 15 Oct 2026
OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences - 30 Sept 2026
MetaviewMetaview unlocks a £45m Series C led by Insight Partners to automate hiring with sourcing and screening agents
Series CHR - 23 Sept 2026
Basecamp ResearchBasecamp Research unlocks £105m Series C led by S32 to design medicines with frontier AI models
Series CLife Sciences
